^
Association details:
Biomarker:No biomarker
Cancer:Colorectal Cancer
Drug:5-fluorouracil (Thymidylate synthase inhibitor) +
leucovorin calcium (Folate analog)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Colorectal cancer...for patients with impaired tolerance to aggressive initial therapy, the guidelines recommend infusional 5-FU/LV or capecitabine with or without bevacizumab as an option.